Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Jul 30, 2020 10:24pm
192 Views
Post# 31347634

You Needs to compare apple to apple, lets see your examples

You Needs to compare apple to apple, lets see your examples(1) Therma Bright Inc THRM: - market cap $32.7 million.
Still developing A RAPID TEST TO DETECT COVID-19 VIRUS IN SALIVA (no where close to sell)

(2) Loop Insights Inc MTRX: - Market cap $28.3 Million.
Started conversations for the implementation of its COVID-19 contact tracing solution. (demand is not as much as Covid-19 tests in USA)

(3) Naturally Splendid Enterprises Ltd NSP: - Market cap $13.8 Million
What do they really offer hemp or COVID-19 clinical trial? (No where close to selling)

(4) Vaxil Bio Ltd. VXL: - Market cap 10.3 Million
Vaxil Bio begins animal study for COVID-19 vaccine (started study, no where close to selling)

(5) MedMira Inc MIR: - Market cap $276.5 Million
They have Exclusive Distribution Agreement with Webb Diagnostic Technologies, Inc. (Not many sales)

So, from all these examples you provided, only one compare with Questcap (QSC) and that is Medmira (MIR). Questcap Market cap with $0.085 comes to $7.6 million compare to Medmira $276 million. Do you really think that is very smart “Nah.”?  Do your calculation again see what you get and maybe stay away from shoring. If you already did cover it first thing in the morning before it is too late. Thanks

<< Previous
Bullboard Posts
Next >>